0001285550-23-000050.txt : 20230525 0001285550-23-000050.hdr.sgml : 20230525 20230525162353 ACCESSION NUMBER: 0001285550-23-000050 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230525 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ClearPoint Neuro, Inc. CENTRAL INDEX KEY: 0001285550 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582394628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34822 FILM NUMBER: 23960987 BUSINESS ADDRESS: STREET 1: 120 S. SIERRA AVENUE STREET 2: SUITE 100 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 9499006833 MAIL ADDRESS: STREET 1: 120 S. SIERRA AVENUE STREET 2: SUITE 100 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: MRI INTERVENTIONS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: SURGIVISION INC DATE OF NAME CHANGE: 20091106 FORMER COMPANY: FORMER CONFORMED NAME: SURGI VISION INC DATE OF NAME CHANGE: 20040331 8-K 1 clpt-20230525.htm 8-K clpt-20230525
0001285550FALSE12/3100012855502023-05-252023-05-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________
FORM 8-K
_________________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 25, 2023
_________________________________________
CLEARPOINT NEURO, INC.
(Exact name of registrant as specified in its charter)
_________________________________________
 
Delaware
001-3482258-2394628
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
120 S. Sierra Ave., Suite 100
Solana BeachCA 92075
(Address of principal executive offices, zip code)
(888) 287-9109
(Registrant’s telephone number, including area code)
_________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per shareCLPTNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
At the 2023 annual meeting of the stockholders (the “Annual Meeting”) of ClearPoint Neuro, Inc. (the “Company”) held on May 24, 2023, the Company’s stockholders approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to reduce the number of authorized shares of the Company’s common stock from two hundred million (200,000,000) shares to ninety million (90,000,000) shares. No other changes were made to the Company’s certificate of incorporation. The foregoing description of the Certificate of Amendment is only a summary and is qualified in its entirety by the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 5.07    Submission of Matters to a Vote of Security Holders.
At the Annual Meeting, the Company’s stockholders considered and voted on the following proposals:

(1)The election of eight directors to serve until the 2024 annual meeting of stockholders;
(2)The ratification of the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
(3)The advisory approval of executive compensation; and
(4)The approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation.

Each proposal was approved and the final voting results for each proposal are described below. For beneficial owners holding the Company’s common stock at a bank or broker institution, a “broker non-vote” occurred if the owner failed to give voting instructions, and the bank or broker was otherwise restricted from voting on the owner’s behalf.

1.Election of Directors. The following named persons were elected as directors of the Company to serve until the 2024 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal. The votes were cast as follows:

NameForWithheldBroker Non-Votes
Joseph M. Burnett9,508,775 65,864 4,856,372 
R. John Fletcher8,847,706 726,933 4,856,372 
Lynnette C. Fallon8,767,508 807,131 4,856,372 
Pascal E.R. Girin8,847,611 727,028 4,856,372 
B. Kristine Johnson8,784,039 790,600 4,856,372 
Matthew B. Klein9,508,771 65,868 4,856,372 
Linda M. Liau9,504,476 70,163 4,856,372 
Timothy T. Richards8,848,151 726,488 4,856,372 

2.Ratification of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The votes were cast as follows:

ForAgainstAbstentionsBroker Non-Votes
14,419,693 3,150 8,168 — 


3.Advisory approval of executive compensation. The stockholders, on an advisory basis, approved the compensation of the Company’s executives. The votes were cast as follows:




ForAgainstAbstentionsBroker Non-Votes
9,224,361 127,029 223,249 4,856,372 

4.Approval of the Amendment to the Amended and Restated Certificate of Incorporation. The stockholders approved the amendment to the Company’s Amended and Restated Certificate of Incorporation. The votes were cast as follows:

ForAgainstAbstentionsBroker Non-Votes
14,331,081 14,944 84,986 — 
Item  9.01     Financial Statements and Exhibits.
(d) Exhibits
Exhibit NumberDescription
Exhibit 3.1
Exhibit 104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 25, 2023
CLEARPOINT NEURO, INC.
 
By:
/s/ Danilo D’Alessandro
Danilo D’Alessandro
Chief Financial Officer
 

EX-3.1 2 clptcertificateofamendment.htm EX-3.1 Document

Exhibit 3.1
CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
CLEARPOINT NEURO, INC.
________________________________________

Pursuant to Section 242 of the General
Corporation Law of the State of Delaware
________________________________________

CLEARPOINT NEURO, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:

1.Section A of Article IV of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended in its entirety to read as follows:

A. Authorized Stock. The total number of shares which the Corporation shall have authority to issue is One Hundred Fifteen Million (115,000,000), consisting of Ninety Million (90,000,000) shares of Common Stock, par value $0.01 per share (the “Common Stock”), and Twenty Five Million (25,000,000) shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”).”

1.The amendment to the Amended and Restated Certificate of Incorporation of the Corporation effected hereby has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

1.This Certificate of Amendment will become effective as of 12:01 a.m. EST on May 25, 2023.


IN WITNESS WHEREOF, the Corporation has caused this certificate to be signed by its duly authorized officer this 24th day of May, 2023.


CLEARPOINT NEURO, INC.


By: /s/ Joseph Burnett        
Name: Joseph Burnett
Title: President and Chief Executive Officer


EX-101.SCH 3 clpt-20230525.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 clpt-20230525_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key EX-101.PRE 5 clpt-20230525_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
May 25, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 25, 2023
Entity Registrant Name CLEARPOINT NEURO, INC
Entity Incorporation, State or Country Code DE
Entity File Number 001-34822
Entity Tax Identification Number 58-2394628
Entity Address, Address Line One 120 S. Sierra Ave., Suite 100
Entity Address, City or Town Solana Beach
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92075
City Area Code (888)
Local Phone Number 287-9109
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol CLPT
Entity Emerging Growth Company false
Amendment Flag false
Current Fiscal Year End Date --12-31
Entity Central Index Key 0001285550
XML 7 clpt-20230525_htm.xml IDEA: XBRL DOCUMENT 0001285550 2023-05-25 2023-05-25 0001285550 false --12-31 8-K 2023-05-25 CLEARPOINT NEURO, INC DE 001-34822 58-2394628 120 S. Sierra Ave., Suite 100 Solana Beach CA 92075 (888) 287-9109 false false false false Common Stock, $0.01 par value per share CLPT false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://clearpointneuro.com/role/Cover Cover Cover 1 false false All Reports Book All Reports clpt-20230525.htm clpt-20230525.xsd clpt-20230525_lab.xml clpt-20230525_pre.xml clptcertificateofamendment.htm http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clpt-20230525.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "clpt-20230525.htm" ] }, "labelLink": { "local": [ "clpt-20230525_lab.xml" ] }, "presentationLink": { "local": [ "clpt-20230525_pre.xml" ] }, "schema": { "local": [ "clpt-20230525.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clpt", "nsuri": "http://clearpointneuro.com/20230525", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clpt-20230525.htm", "contextRef": "i6c32d1a152cd4458b58011ec458049f8_D20230525-20230525", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://clearpointneuro.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clpt-20230525.htm", "contextRef": "i6c32d1a152cd4458b58011ec458049f8_D20230525-20230525", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://clearpointneuro.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001285550-23-000050-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001285550-23-000050-xbrl.zip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